Our findings suggest that distinct molecular events contribute to these two phenotypes, with PTEN, SYN1, and BDNF polymorphisms possibly playing a role in TRD, while MAPK1 and GSK3B may be associated with relapse predisposition. Here, PTEN is linked to treatment resistant depression.